deaths (OS)

mBC - TNBC - L1 - all population breast cancer - triple negative mBC - Triple negative (TNBC) - 1st Line (L1) mBC - TNBC - L1 - all population

versus Standard of Care (SoC)
veliparib plus paclitaxel plus carboplatin vs. Standard of Care (SoC) 2 certainty unassessable-17%